News
For now, NB.1.8.1 accounts for fewer than 20 reported cases nationwide, USA Today reported – but the transmissibility of the ...
23h
Zacks Investment Research on MSNModerna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspikeModerna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...
Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.
Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...
Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...
Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the ...
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he urged them to consult with their doctors.
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results